Clinical Trial Update: Along-term Study of OPC-262 in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 long-term study of OPC-262 in patients with Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• OPC-262

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: Diabetes, Type 2 | Phase 3 | Status: COMPLETED